Medical Diagnostics

Selected news for the healthcare topic - Medical Diagnostics, collected since 10/2017. This healthcare topic shares news with COVID-19, COVID-19 Testing, Medical Imaging, Telemedicine Platform, Infectious Disease and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
9/12/2021 Zacks Investment Research Upgrades Check-Cap (NASDAQ:CHEK) to Buy thelincolnianonline.com ... buy rating in a research report released on Wednesday morning, Zacks.com reports. The brokerage currently has $1.25 price objective on the medical research company’s stock.According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. “Separately, HC Wainwright cut their ...
9/12/2021 Zacks Investment Research Upgrades Check-Cap (NASDAQ:CHEK) to Buy - The Cerbat Gem thecerbatgem.com ... to a buy rating in a research note released on Wednesday, Zacks.com reports. They currently have $1.25 price objective on the medical research company’s stock.According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. “Separately, HC Wainwright lowered their ...
9/12/2021 Check-Cap (NASDAQ:CHEK) Downgraded by Zacks Investment Research com-unik.info Zacks Investment Research downgraded shares of Check-Cap (NASDAQ:CHEK) from a buy rating to a hold rating in a research report report published on Thursday morning, Zacks.com reports. According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. “ Separately, HC ...
9/12/2021 Zacks Investment Research Downgrades Check-Cap (NASDAQ:CHEK) to Hold dispatchtribunal.com Zacks Investment Research cut shares of Check-Cap (NASDAQ:CHEK) from a buy rating to a hold rating in a research report report published on Thursday morning, Zacks.com reports. According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. “ Separately, HC ...
9/11/2021 Mining Chemicals Market Solid Analyzed Segmentation, Demand, Recent Share Estimation and Growth Prospects by Regions to 2024 tradersherald.com ... Segment by Regions North America Europe China Japan Southeast Asia India Segment by Type Automated Dry Blotting Systems Semi-Dry Blotting Systems Traditional Wet Transfer Blotting Systems Segment by Application Agricultural Application Food & Beverages Medical Diagnostics Scientific Research Other Applications Make An Enquiry About This Report @ https://www.researchmoz.us/enquiry.php?type=E&repid=2521002&source=atm Reasons to Purchase this Mining Chemicals Market Report: Analyzing the outlook of the market with ...
9/10/2021 AI in Medical Diagnostics Market | Qualitative Analysis on Key Players and 2028 Forecasts on Industry Scenario saltlakecityheadlines.com The market report “Artificial Intelligence (AI) in Medical Diagnostics Market by Technologies (In Vivo Diagnostics and In Vitro Diagnostics (IVD)), Components (Software, Service and Hardware), Applications (Follow-Up Plan, Data Mining, Image Acquisition, Data Storage and Processing to Aided Reporting), End Users (Diagnostic Laboratory & Imaging Center and Hospital), and Region – Forecast to 2028”. The artificial intelligence (AI) in medical diagnostics market is growing at a CAGR of 52.2 ...
9/10/2021 AI in Medical Diagnostics Market | Qualitative Analysis on Key Players and 2028 Forecasts on Industry Scenario ussharemarkets.com The market report “Artificial Intelligence (AI) in Medical Diagnostics Market by Technologies (In Vivo Diagnostics and In Vitro Diagnostics (IVD)), Components (Software, Service and Hardware), Applications (Follow-Up Plan, Data Mining, Image Acquisition, Data Storage and Processing to Aided Reporting), End Users (Diagnostic Laboratory & Imaging Center and Hospital), and Region – Forecast to 2028”. The artificial intelligence (AI) in medical diagnostics market is growing at a CAGR of 52.2 ...
9/10/2021 AI in Medical Diagnostics Market | Qualitative Analysis on Key Players and 2028 Forecasts on Industry Scenario salemnewsheadlines.com The market report “Artificial Intelligence (AI) in Medical Diagnostics Market by Technologies (In Vivo Diagnostics and In Vitro Diagnostics (IVD)), Components (Software, Service and Hardware), Applications (Follow-Up Plan, Data Mining, Image Acquisition, Data Storage and Processing to Aided Reporting), End Users (Diagnostic Laboratory & Imaging Center and Hospital), and Region – Forecast to 2028”. The artificial intelligence (AI) in medical diagnostics market is growing at a CAGR of 52.2 ...
9/10/2021 AI in Medical Diagnostics Market | Qualitative Analysis on Key Players and 2028 Forecasts on Industry Scenario newslighthouse.com The market report “Artificial Intelligence (AI) in Medical Diagnostics Market by Technologies (In Vivo Diagnostics and In Vitro Diagnostics (IVD)), Components (Software, Service and Hardware), Applications (Follow-Up Plan, Data Mining, Image Acquisition, Data Storage and Processing to Aided Reporting), End Users (Diagnostic Laboratory & Imaging Center and Hospital), and Region – Forecast to 2028”. The artificial intelligence (AI) in medical diagnostics market is growing at a CAGR of 52.2 ...
9/10/2021 Zacks Investment Research Upgrades Check-Cap (NASDAQ:CHEK) to “Buy” theenterpriseleader.com ... on the medical research company’s stock. Zacks Investment Research ‘s target price would indicate a potential upside of 19.05% from the company’s previous close. According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. “ Separately, HC Wainwright cut their ...
9/10/2021 Check-Cap (NASDAQ:CHEK) Lowered to “Hold” at Zacks Investment Research The Markets Daily Zacks Investment Research lowered shares of Check-Cap (NASDAQ:CHEK) from a buy rating to a hold rating in a research note published on Thursday, Zacks.com reports. According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. “ Separately, HC Wainwright cut ...
9/10/2021 Deer Park Tribune dptribune.com Global Artificial Intelligence (AI) in Medical Diagnostics Market is expected to reach US $ 14,541.47 MN By Forecast year 2028 Artificial Intelligence (AI) in Medical Diagnostics market Data And Industry Growth Analysis Stratistics Market Research Consulting The market report “Artificial Intelligence (AI) in Medical Diagnostics Market by Technologies (In Vivo Diagnostics and In Vitro Diagnostics (IVD)), Components (Software, Service and Hardware), Applications (Follow-Up Plan, Data Mining, Image Acquisition, Data Storage ...
9/7/2021 CND Life Sciences Adds Biopharma Veteran to Its Board PR Newswire ... the Life Sciences Industry to Support the Company's Mission News provided by Sep 07, 2021, 10:32 ET Share this article Share this articlePHOENIX , Sept. 7, 2021 /PRNewswire/ -- CND Life Sciences, Inc. , an innovative medical diagnostics company pioneering the detection and visualization of abnormal proteins in cutaneous nerve fibers, today announced the appointment of Enrique Carrazana , MD, to its board of directors. Dr. Carrazana is a Harvard trained neurologist with ...
9/7/2021 Genetic Testing Pioneer DnaNudge Signs Key Agreement With Spain's Largest Clinical Group Quirónprevención digitalmedianet.com Published Date: September 7, 2021 New strategic partnership with Quirónprevención to speed commercial deployment of breakthrough rapid genetic testing solutions across SpainLONDON–(BUSINESS WIRE)–Consumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has signed a new major distributor agreement that will speed the commercial roll-out of its breakthrough rapid genetic testing solutions across Spain.The new strategic partnership with Madrid-based ...
9/7/2021 Genetic Testing Pioneer DnaNudge Signs Key Agreement With Spain's Largest Clinical Group Quirónprevención Yahoo News New strategic partnership with Quirónprevención to speed commercial deployment of breakthrough rapid genetic testing solutions across SpainLONDON, September 07, 2021 --( BUSINESS WIRE )--Consumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has signed a new major distributor agreement that will speed the commercial roll-out of its breakthrough rapid genetic testing solutions across Spain.The new strategic partnership with Madrid-based Quirónprevención ...
9/7/2021 Genetic Testing Pioneer DnaNudge Signs Key Agreement With Spain's Largest Clinical Group Quirónprevención | Business Wire Business Wire LONDON--( BUSINESS WIRE )--Consumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has signed a new major distributor agreement that will speed the commercial roll-out of its breakthrough rapid genetic testing solutions across Spain.The new strategic partnership with Madrid-based Quirónprevención, grants the experienced distributor the exclusive rights to market and sell DnaNudge’s Nutrition Service, the upcoming DnaNudge Skincare service, and the ...
9/7/2021 Genetic Testing Pioneer DnaNudge Signs Key Agreement With Spain's Largest Clinical Group Quir√≥nprevenci√≥n mangaloremirror.com ... Äôs Largest Clinical Group Quir√≥nprevenci√≥n New strategic partnership with Quir√≥nprevenci√≥n to speed commercial deployment of breakthrough rapid genetic testing solutions across Spain LONDON‚Äì(BUSINESS WIRE)‚ÄìConsumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has signed a new major distributor agreement that will speed the commercial roll-out of its breakthrough rapid genetic testing solutions across Spain. The new strategic partnership with ...
9/5/2021 VIXC - Market and Financial News Online Magazine. vixc.com ... investors have poured more than $200m into three start-ups that are trying to build small blood-testing devices, in a sign that the Theranos scandal has not harmed the rapidly growing market for medical diagnostics . Verily, the life sciences division of Google’s parent company Alphabet, led a $50m round of financing in January for Genalyte, which has created a benchtop machine that promises to perform multiple rapid tests ...
9/5/2021 The Coretec Group Builds on its Intellectual Property Portfolio with Si Quantum Dots dubaiglobalnews.com ... adoption. The Coretec Group has leveraged its existing intellectual property, targeted routes, and unique chemistries that will meet the requirements of LED manufacturers along with silicon anodes for next-generation batteries, drug delivery, and medical diagnostics . Most Quantum dots (QDs) on the market today contain toxic metals that severely limit their market reach as well as can be harmful to the environment. SiQDs are metal-free QDs that possess all ...
9/5/2021 The Coretec Group Builds on its Intellectual Property Portfolio with Si Quantum Dots iconiclady.com ... adoption. The Coretec Group has leveraged its existing intellectual property, targeted routes, and unique chemistries that will meet the requirements of LED manufacturers along with silicon anodes for next-generation batteries, drug delivery, and medical diagnostics . Most Quantum dots (QDs) on the market today contain toxic metals that severely limit their market reach as well as can be harmful to the environment. SiQDs are metal-free QDs that possess all ...